Receh.in - Shares of large-cap lender PT Bank Mandiri Tbk (BMRI) soared in early Wednesday trading. At 9:45 a.m. local time, BMRI shares rose 1.01% to IDR 10,050 ($0.69) per unit, returning to the IDR 10,000 ($0.68) range.
BMRI was also the only stock able to hold off the decline of the benchmark Jakarta Composite Index (IHSG) in early trading, helping to minimize the index's 4.82 point drop.
The rise in BMRI's share price followed the purchase of 100,000 BMRI shares by the company's CEO, Darmawan Junaidi. The transaction, which took place on December 9, 2022 at a price of IDR 9,950 ($0.68) per share, was valued at IDR 995 million ($68,000).
"The purpose of the transaction was for investment," Junaidi said in a disclosure statement on Wednesday.
Prior to the transaction, Junaidi owned 2,106,100 BMRI shares, or about 0.00451307%. After the purchase, he now owns 2,206,100 shares, or about 0.00472736%.
In addition to the CEO, the Commercial Banking Director of Bank Mandiri, Riduan, also purchased 40,000 BMRI shares on December 28, 2022 at a price of IDR 9,900 ($0.67) per share, with the stated purpose of direct ownership investment. As a result, Riduan's ownership of BMRI shares increased from 1,942,000 shares, or 0.0041%, to 1,982,000 shares, or 0.0042%.
According to the orderbook, there have been 48,090 lots of BMRI shares traded as of 9:45 a.m. local time. In detail, there have been 2,524 lots in the bid order or buy at a price of IDR 10,050 per unit, and 6,180 lots in the offer order or sell at a price of IDR 10,075 per unit.
.png)
0 Komentar